FI113266B - Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon - Google Patents
Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon Download PDFInfo
- Publication number
- FI113266B FI113266B FI20021652A FI20021652A FI113266B FI 113266 B FI113266 B FI 113266B FI 20021652 A FI20021652 A FI 20021652A FI 20021652 A FI20021652 A FI 20021652A FI 113266 B FI113266 B FI 113266B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- compound
- trazodone
- chlorophenyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (3)
1. Förening, kännetecknad avatt den är 1-(3-klorfenyl)-3-alkylpiperazin med formeln (IV) 5 R" R"‘ Cl HN N-( /} (IV) väri R”’ är väteatom och R” är Ci-3-alkylgrupp.
2. Förening som är användbar vid framställning av en förening enligt 10 patentkrav 1, kännetecknad avatt den är 1-(3-klorfenyl)-3-alkylpipe- razin-2-on med formeln (V) R"i) Cl HNwN^^ (V) 15 väri R” är Ci.3-alkylgrupp.
3. Förening som är användbar vid framställning av en förening enligt / patentkrav 2, kännetecknad av att den är N-(3-klorfenyl)-N'-(1-alkyl-2- karboxy)etyldiamin med formeln (VI) ; ·· R" Cl ^—COOH /=/ HN NH—(\ /> (VI) v_y \_/ väri R” är Ci.3-alkylgrupp. > ·
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI920084A IT1258790B (it) | 1992-01-17 | 1992-01-17 | Alchil derivati del trazodone |
| ITMI920084 | 1992-01-17 | ||
| EP9300080 | 1993-01-14 | ||
| PCT/EP1993/000080 WO1993014091A1 (en) | 1992-01-17 | 1993-01-14 | Alkyl derivatives of trazodone with cns activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20021652A FI20021652A (sv) | 2002-09-16 |
| FI113266B true FI113266B (sv) | 2004-03-31 |
Family
ID=11361589
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943386A FI110186B (sv) | 1992-01-17 | 1994-07-15 | Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat |
| FI20021652A FI113266B (sv) | 1992-01-17 | 2002-09-16 | Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943386A FI110186B (sv) | 1992-01-17 | 1994-07-15 | Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0623131B1 (sv) |
| JP (1) | JP2856912B2 (sv) |
| KR (1) | KR100254690B1 (sv) |
| AT (1) | ATE136307T1 (sv) |
| AU (1) | AU671973B2 (sv) |
| BG (1) | BG61841B1 (sv) |
| BR (1) | BR9305752A (sv) |
| CA (1) | CA2128202C (sv) |
| CZ (1) | CZ282910B6 (sv) |
| DE (1) | DE69302087T2 (sv) |
| DK (1) | DK0623131T3 (sv) |
| ES (1) | ES2088270T3 (sv) |
| FI (2) | FI110186B (sv) |
| GE (1) | GEP20001939B (sv) |
| GR (1) | GR3020420T3 (sv) |
| HU (5) | HU218678B (sv) |
| IT (1) | IT1258790B (sv) |
| NO (2) | NO302365B1 (sv) |
| NZ (1) | NZ246598A (sv) |
| PL (1) | PL170913B1 (sv) |
| RO (1) | RO113465B1 (sv) |
| RU (1) | RU2126801C1 (sv) |
| SK (1) | SK280561B6 (sv) |
| WO (1) | WO1993014091A1 (sv) |
| ZA (1) | ZA93292B (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU718075B2 (en) * | 1993-07-01 | 2000-04-06 | Angelini Ricerche S.P.A. Societa Consortile | Intermediates for the preparation of pharmacologically active enantiomers of triazolone compounds |
| IT1268414B1 (it) * | 1993-07-01 | 1997-02-27 | Angelini Francesco Ist Ricerca | Enantiomeri farmacologicamente attivi |
| TW200726765A (en) * | 2005-06-17 | 2007-07-16 | Bristol Myers Squibb Co | Triazolopyridine cannabinoid receptor 1 antagonists |
| ITMI20051193A1 (it) * | 2005-06-24 | 2006-12-25 | Acraf | Uso farmaceutico di una 1-3-clorofenil-3-alchilpiperazina |
| WO2012072665A1 (en) | 2010-11-30 | 2012-06-07 | Pharmaneuroboost N.V. | Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors |
| RU2706700C1 (ru) | 2019-09-24 | 2019-11-20 | Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" | Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US100505A (en) * | 1870-03-08 | Improvement in sash-bolt | ||
| IT1066857B (it) * | 1965-12-15 | 1985-03-12 | Acraf | Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione |
-
1992
- 1992-01-17 IT ITMI920084A patent/IT1258790B/it active IP Right Grant
- 1992-01-17 GE GEAP19922648A patent/GEP20001939B/en unknown
-
1993
- 1993-01-14 HU HU9402119A patent/HU218678B/hu not_active IP Right Cessation
- 1993-01-14 AT AT93902204T patent/ATE136307T1/de not_active IP Right Cessation
- 1993-01-14 NZ NZ246598A patent/NZ246598A/xx not_active IP Right Cessation
- 1993-01-14 WO PCT/EP1993/000080 patent/WO1993014091A1/en active IP Right Grant
- 1993-01-14 JP JP5512150A patent/JP2856912B2/ja not_active Expired - Fee Related
- 1993-01-14 CZ CZ941732A patent/CZ282910B6/cs not_active IP Right Cessation
- 1993-01-14 RO RO94-01203A patent/RO113465B1/ro unknown
- 1993-01-14 AU AU33504/93A patent/AU671973B2/en not_active Ceased
- 1993-01-14 RU RU94036769A patent/RU2126801C1/ru not_active IP Right Cessation
- 1993-01-14 PL PL93304665A patent/PL170913B1/pl not_active IP Right Cessation
- 1993-01-14 CA CA002128202A patent/CA2128202C/en not_active Expired - Fee Related
- 1993-01-14 DE DE69302087T patent/DE69302087T2/de not_active Expired - Fee Related
- 1993-01-14 BR BR9305752A patent/BR9305752A/pt not_active Application Discontinuation
- 1993-01-14 DK DK93902204.2T patent/DK0623131T3/da active
- 1993-01-14 ES ES93902204T patent/ES2088270T3/es not_active Expired - Lifetime
- 1993-01-14 HU HU9502179A patent/HU217968B/hu not_active IP Right Cessation
- 1993-01-14 SK SK846-94A patent/SK280561B6/sk not_active IP Right Cessation
- 1993-01-14 KR KR1019940702475A patent/KR100254690B1/ko not_active IP Right Cessation
- 1993-01-14 EP EP93902204A patent/EP0623131B1/en not_active Expired - Lifetime
- 1993-01-15 ZA ZA93292A patent/ZA93292B/xx unknown
-
1994
- 1994-07-08 BG BG98896A patent/BG61841B1/bg unknown
- 1994-07-15 FI FI943386A patent/FI110186B/sv active
- 1994-07-15 NO NO942668A patent/NO302365B1/no not_active IP Right Cessation
-
1995
- 1995-07-19 HU HU9502180A patent/HU217982B/hu not_active IP Right Cessation
- 1995-07-19 HU HU9502178A patent/HU217981B/hu not_active IP Right Cessation
- 1995-07-19 HU HU9502177A patent/HU219493B/hu not_active IP Right Cessation
-
1996
- 1996-07-02 GR GR960401793T patent/GR3020420T3/el unknown
-
1997
- 1997-09-26 NO NO974462A patent/NO303686B1/no not_active IP Right Cessation
-
2002
- 2002-09-16 FI FI20021652A patent/FI113266B/sv active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880001374B1 (ko) | 항우울증 치료제인 2-펜옥시알킬-1,2,4-트리아졸-3-온 및 그의 제조방법 | |
| US4487773A (en) | 1,2,4-Triazol-3-one antidepressants | |
| FI93104B (sv) | Analogiförfarande för framställning av terapeutiskt användbara substituerade imidazolylalkylpiperazin- och -diazepinderivat | |
| FR2521561A1 (fr) | Derives de benzisothiazole et benzisoxale piperazine | |
| SE465928B (sv) | 1,2,4-triazolonfoereningar med antidepressiv aktivitet, foerfarande foer framstaellning av dessa och en farmaceutisk komposition | |
| FI113266B (sv) | Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon | |
| HUT71347A (en) | Novel process for preparing chiral {[(2-bromoethyl)-amino]-methyl}-2-nitro-1h-imidazol-1-ethanol and related compounds | |
| JP2002533332A (ja) | 治療活性化合物としてのスルホニルオキサゾールアミン成分 | |
| FI73980C (sv) | Förfarande för framställning av (-)-2-/1-(2,6-diklorfenoxi)-etyl-/1,3- diazacyklopent-2-en | |
| HU203345B (en) | Process for producing ergoline derivatives and pharmaceutical compositions comprising same | |
| JPS63316778A (ja) | ３−ヘテロアルキル−２，４−キナゾリンジオン、３−ヘテロアリ−ル−１，２，３−ベンゾトリアジン−４（３ｈ）−オン、３−ヘテロアリ−ルアルキル−４−キナゾリノン | |
| US5543563A (en) | Alkyl derivatives of trazodone with CNS activity | |
| CA2007401A1 (fr) | Derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
| NZ510042A (en) | N-substituted azabicycloheptane derivatives useful as neuroleptics, antidepressants, sedatives or hypnotics | |
| FI111943B (sv) | Analogiförfarande för framställning av en terapeutiskt användbar enantiomer förening, som är (S)- eller (R)-2-[3[4-(3-klorfenyl)-1-(2-alkyl)-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3-(2H)-on,och mellanprodukter | |
| JP2003530396A (ja) | Ｃｃｋ阻害剤の治療上有用な新規な塩、その調製方法およびそれらを含有する医薬製品 | |
| BG60318B2 (bg) | Метод за получаване на триазолил тиоамидни производни | |
| SK812001A3 (en) | N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES, PRODUCTION AND USEì (54) THEREOF | |
| CZ292867B6 (cs) | Způsob cyklizace anilinových derivátů |